Akerna Corp KERN is moving higher on Wednesady morning after business intelligence from the company showed that April 20 had the highest retail cannabis sales ever recorded.
Approximately $111.8 million was recorded in medical and adult-use sales on the unofficial cannabis holiday "4/20."
Financial Results: Akerna last reported financial results on March 22.
"In the December quarter we delivered strong financial results, with 38 percent software growth year over year and 36 percent sequential improvement in adjusted EBITDA," said CEO Jessica Billingsley.
Price Action: Akerna has traded as high as $11.49 and as low as $2.17 over a 52-week period.
The stock was up 3.4% to $4.50 at last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.